Beone Medicines Ltd. Class ASSE: 688235

"BEONE MEDICINES LTD."Grant of Restricted Share Units

Jul 9, 2026 · Issued by Beone Medicines Ltd. Class A via Shanghai Stock Exchange

Watch Beone Medicines Ltd. Class A explain itBeOne Medicines Ltd. (ONC) Q2 2026 Earnings Call · Replay · Aug 5

Grant of Restricted Share Units

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Beone Medicines Ltd. Class A

"BEONE MEDICINES LTD."Voluntary Announcement on Progress of Clinical Trial of BRUKINSA (Zanubrutinib Capsules)Jul 1
Announcement on the Handling of Relevant Tax MattersJun 27
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% ScaleJun 2
BeOne Medicines’ BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell LymphomaMay 13

All Beone Medicines Ltd. Class A news releases